Lantz Financial LLC Sells 218 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Lantz Financial LLC decreased its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 1.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 21,905 shares of the biopharmaceutical company’s stock after selling 218 shares during the quarter. Lantz Financial LLC’s holdings in Gilead […]